ArticlePloS one2019

Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.

Cristina Vazquez-Mateo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.